Skip to main content
Veterinary Medicines

SEVOFLUTEK 1000 mg/g Inhalation vapour, liquid for dogs

Authorised
  • Sevoflurane

Product identification

Medicine name:
SEVOFLUTEK 1000 mg/g Inhalation vapour, liquid for dogs
Sevotek 1000 mg/g vloeistof voor inhalatiedamp voor honden en katten.
Active substance:
  • Sevoflurane
Target species:
  • Dog
  • Cat
Route of administration:
  • Inhalation use

Product details

Active substance and strength:
  • Sevoflurane
    1000.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Inhalation vapour, liquid
Withdrawal period by route of administration:
  • Inhalation use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AB08
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • box containing 1 bottle of 250 ml

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Karizoo S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Karizoo S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 120710
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0278/001
Concerned member states:
  • Belgium
  • Czechia
  • Denmark
  • France
  • Germany
  • Hungary
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Sweden

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 19/01/2022

Summary of Product Characteristics

English (PDF)
Published on: 22/12/2023
Download

Package Leaflet

English (PDF)
Published on: 22/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."